Showing results (1-10 of 191) with videos related to
Sort By:
Pageof 20
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 1, 1996
Atrial natriuretic peptide levels in the elderly: differentiating normal aging changes from diseaseK M Davis, L C Fish, K L Minaker, et al.JAMA|May 20, 1992
Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderlyK M Davis, L C Fish, D Elahi, et al.Geriatric Nephrology and Urology|January 1, 1997
Effects of hypertonicity on water intake in the elderly: an age-related failureM McAloon Dyke, K M Davis, B A Clark, et al.Journal of the American Geriatrics Society|April 15, 1999
Atrial natriuretic peptide and the development of congestive heart failure in the oldest old: a seven-year prospective studyE L Knight, L C Fish, D K Kiely, et al.The Journal of Clinical Endocrinology and Metabolism|August 26, 1998
The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulinG S Meneilly, A S Ryan, K L Minaker, et al.Metabolism: Clinical and Experimental|March 1, 1988
Somatostatin infusion enhances hepatic glucose production during hyperglucagonemiaG S Meneilly, K L Minaker, D Elahi, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1988
Somatostatin enhances insulin-mediated glucose disposal in elderly subjectsG S Meneilly, D Elahi, K L Minaker, et al.Journal of Gerontology|March 1, 1987
Insulin action in aging man: evidence for tissue-specific differences at low physiologic insulin levelsG S Meneilly, K L Minaker, D Elahi, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1986
The dawn phenomenon does not occur in normal elderly subjectsG S Meneilly, D Elahi, K L Minaker, et al.The Journal of Clinical Endocrinology and Metabolism|August 1, 1987
Somatostatin does not alter insulin-mediated glucose disposalG S Meneilly, D Elahi, K L Minaker, et al.Pageof 20